Skip to menu Skip to content Skip to footer

2007

Conference Publication

Investigating the role of single patient trial as a means of gathering population level evidence in palliative care

Mitchell, G., Nikles, J., Hardy, J., Currow, D., Good, P., Rowett, D. and Walters, J. (2007). Investigating the role of single patient trial as a means of gathering population level evidence in palliative care. Clinical Oncological Society of Australia 34th Annual Scientific Meeting, Adelaide, Australia, 14-16 November, 2007. Carlton, Australia: Blackwell Publishing. doi: 10.1111/j.1743-7563.2007.00127.x

Investigating the role of single patient trial as a means of gathering population level evidence in palliative care

1990

Conference Publication

NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER

HARDY, J, TAN, S, FRYATT, and WILTSHAW, E (1990). NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER. BASINGSTOKE: STOCKTON PRESS.

NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER

1990

Conference Publication

Dose intensity in ovarian-cancer

Hardy, J. R., Hryniuk, W. M. and Wiltshaw, E. (1990). Dose intensity in ovarian-cancer. 31st Annual Meeting of the British Association of Cancer Research and the 5th Annual Meeting of the Association of Cancer Physicians, Sussex, United Kingdom, 19-22 March 1990. London, United Kingdom: Nature Publishing Group. doi: 10.1038/bjc.1990.324

Dose intensity in ovarian-cancer

1990

Conference Publication

Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac)

Jones, A. L., Powles, T. J., Judson, I. R., Hardy, J. R. and Ashley, S. E. (1990). Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac). 31st annual meeting of the British Association of Cancer Research and the 5th annual meeting of the Association of Cancer Physicians, Sussex, United Kingdom, 19-22 March 1990. BASINGSTOKE: STOCKTON PRESS. doi: 10.1038/bjc.1990.324

Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac)

1989

Conference Publication

The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study

Evans, PC, Hardy, JR, Paxton, JW, Harvey, VJ and Baguley, BC (1989). The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study. WELLINGTON: NEW ZEALAND MED ASSN.

The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study

1989

Conference Publication

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women

Lonning, PE, Dowsett, M, Jacobs, S, Schem, B, Hardy, J and Powles, TJ (1989). Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women. 9th International Symp of the Journal of Steroid Biochemistry : Recent Advances in Steroid Biochemistry, Las Palmas Gran Canaria Spain, May 28-31, 1989. doi: 10.1016/0022-4731(89)90143-X

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women